Phase 1 Placebo Controlled Study of the Safety, Activity and Pharmacokinetics of HQK-1001 in Healthy Subjects

NCT00717262 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: HQK-1001
DRUG: placebo

Sponsor

HemaQuest Pharmaceuticals Inc.